Pharmacokinetics and normal scintigraphic appearance of 99mtc aprotinin

Nuclear Medicine Communications

Volumn 26, Issue 6, 2005, Pages 535-539

  Sojan, Sally M ^a   Smyth, Douglas R ^a   Tsopelas, Chris ^a   Mudge, David ^a   Collins, Peter J ^a   Chatterton, Barry E ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Amyloidosis; Aprotinin; Technetium

Indexed keywords

APROTININ; TECHNETIUM 99M;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUSTRALIA; BLOOD POOL SCINTISCANNING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG UPTAKE; DRUG URINE LEVEL; FEMALE; HEART CONTRACTION; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE QUALITY; INTESTINE; LUNG; MALE; NORMAL HUMAN; PROSPECTIVE STUDY; SCINTIGRAPHY; SCINTILLATION CAMERA; SPLEEN; TIME; URINARY EXCRETION; VOLUNTEER;

ADULT; AGED; APROTININ; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REFERENCE VALUES; TISSUE DISTRIBUTION;

EID: 20144385088     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200506000-00009     Document Type: Article

References (15)

1. Sheldon P, Forrester D. Imaging of amyloid arthropathy. Semin Musculoskelet Radiol 2003; 7:195-204.
2. Hawkins PN. Amyloidosis. Med Int 1994; 22:76-82.
3. 99mTc-aprotinin scintigraphy in amyloidosis. J Nucl Med 2003; 44:177-183.
4. Gertz MA. The classification and typing of amyloid deposits. Am J Clin Path 2004; 121:787-789.
5. 123I-labelled serum amyloid P component. N Engl J Med 1990; 323:508-513.
6. 123I serum amyloid P component scintigraphy in 484 patients. Gut 1998; 42:727-734.
7. 123I serum amyloid protein in the detection of familial amyloidosis in oriental cats. J Small Animal Prac 1994; 35:581-586.
8. 2m amyloid in dialysis patients. Kidney Int 2000; 58:873-880.
9. 2-microglobulin amyloid deposits. Kidney Int 1992; 42:915-923.
10. Cardoso I, Barbosa Periera PJ, Damas AM, Saraiva MJM. Aprotinin binding to amyloid fibrils. Eur J Biochem 2000; 267:2307-2311.
11. Taggart DP, Djapardy V, Naik M, Davies A. A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement and myocardial injury in total arterial grafting. J Thorac Cardiovasc Surg 2003; 126:1087-1094.
12. Lemmer JH, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicentre, randomised, double-blinded, placebo-controlled study. J Thorac Cardiovasc Surg 1994; 107:543-551.
13. 99mTc-aprotinin: a new tracer for kidney morphology and function. Eur J Nucl Med 1984; 9:257-260.
14. 99mTc-aprotinin. Eur J Nucl Med 1986; 12:37-40.
15. Aprile C, Marinone G, Saponaro R, Bonino C, Merlini G. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin. Eur J Nucl Med 1995; 22:1393-1401.